Diabetes Prevention & Education for Prediabetes
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Diabetes Prevention Program (DPP) for prediabetes?
Is the Diabetes Prevention Program (DPP) safe for humans?
How is the Diabetes Prevention Program (DPP) treatment different from other treatments for prediabetes?
The Diabetes Prevention Program (DPP) is unique because it focuses on lifestyle changes, such as diet and exercise, to prevent diabetes, rather than relying on medication or surgery. It has been shown to reduce the risk of developing diabetes by 58% over three years, making it a highly effective non-drug approach for people with prediabetes.13468
What is the purpose of this trial?
Type 2 diabetes mellitus is one of the fastest growing public health problems in developed and developing countries and imposes a large financial burden on health-care systems. Preventing, delaying, and managing diabetes should be a priority for health-care systems. Nationally, 38% of adults have prediabetes, with more than 80% of people with prediabetes being unaware of their condition. In Maryland, an estimated 10.5% of adults report prediabetes, and 33.7% of Baltimore City residents have obesity, an important risk factor for prediabetes.The BMDRP aims to increase the capacity of BMDRP hospitals and community partners to offer DPP and DSMT directly in communities and will also increase the number of referrals into these programs.Successful enrollment and completion of DPP has demonstrated reduced risk of developing type 2 diabetes for individuals with pre-diabetes. However, limited data exist on changes in body composition and liver fat in individuals completing DPP. Individuals with pre-diabetes often have obesity and non-alcoholic fatty liver disease. We will evaluate for changes in body fat and liver fat in individuals completing the DPP program.
Eligibility Criteria
This trial is for adults with prediabetes, obesity, or type 2 diabetes who want to prevent or manage their condition. Participants should have a BMI of at least 25 (or 23 if Asian) indicating overweight status. Those with normal blood sugar levels are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Lifestyle Intervention
Participants undergo the Diabetes Prevention Program (DPP) lifestyle intervention, which includes body composition and liver fat analysis
Follow-up
Participants are monitored for changes in liver elastography, body composition, and diabetes control after completing the DPP
Treatment Details
Interventions
- Diabetes Prevention Program (DPP)
- Diabetes Self-Management Training (DSMT)
Diabetes Prevention Program (DPP) is already approved in United States for the following indications:
- Prediabetes
- Type 2 diabetes prevention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Maryland, Baltimore
Lead Sponsor